Table 2 Adverse events
Grade, n% | CPB (n = 124) | CPA (n = 122) | HR (95%) | p-value |
|---|---|---|---|---|
≥ 2 genitourinary fistula | 0 (0) | 0 (0) | NA | 1.000 |
≥ 2 gastrointestinal fistula | 0 (0) | 0 (0) | NA | 1.000 |
≥ 3 gastrointestinal bleeding | 0 (0) | 0 (0) | NA | 1.000 |
≥ 2 hypertension | 31 (25.0) | 5 (4.1) | 7.00 (4.52–6.02) | < 0.001* |
≥ 4 neutropenia | 42 (33.9) | 18 (14.8) | 4.00 (3.83–5.36) | < 0.001* |
≥ 3 thrombosis/embolism | 11 (8.9) | 3 (2.5) | 2.00 (1.48–3.71) | 0.030* |
≥ 2 pain | 38 (30.6) | 34 (27.9) | 3.00 (0.14–4.23) | 0.633 |